Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene
Open Access
- 18 June 2010
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 174
- https://doi.org/10.1186/1475-2875-9-174
Abstract
Effective treatment remains a mainstay of malaria control, but it is unfortunately strongly compromised by drug resistance, particularly in Plasmodium falciparum, the most important human malaria parasite. Although P. falciparum chemoresistance is well recognized all over the world, limited data are available on the distribution and prevalence of pfcrt and pfmdr1 haplotypes that mediate resistance to commonly used drugs and that show distinct geographic differences. Plasmodium falciparum-infected blood samples collected in 2007 at four municipalities of Luanda, Angola, were genotyped using PCR and direct DNA sequencing. Single nucleotide polymorphisms in the P. falciparum pfcrt and pfmdr1 genes were assessed and haplotype prevalences were determined. The most prevalent pfcrt haplotype was S tctVMNT (representing amino acids at codons 72-76). This result was unexpected, since the S tctVMNT haplotype has previously been seen mainly in parasites from South America and India. The CVIET, CVMNT and CVI NT drug-resistance haplotypes were also found, and one previously undescribed haplotype (CVMDT) was detected. Regarding pfmdr1, the most prevalent haplotype was Y EYSNVD (representing amino acids at codons 86, 130, 184, 1034, 1042, 1109 and 1246). Wild haplotypes for pfcrt and pfmdr1 were uncommon; 3% of field isolates harbored wild type pfcrt (CVMNK), whereas 21% had wild type pfmdr1 (NEYSNVD). The observed predominance of the S tctVMNT haplotype in Angola could be a result of frequent travel between Brazil and Angola citizens in the context of selective pressure of heavy CQ use. The high prevalence of the pfcrt S VMNT haplotype and the pfmdr1 86Y mutation confirm high-level chloroquine resistance and might suggest reduced efficacy of amodiaquine in Angola. Further studies must be encouraged to examine the in vitro sensitivity of pfcrt S VMNT parasites to artesunate and amodiaquine for better conclusive data.Keywords
This publication has 32 references indexed in Scilit:
- In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in UgandaAntimicrobial Agents and Chemotherapy, 2010
- Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic areaMalaria Journal, 2009
- Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, AngolaMalaria Journal, 2008
- Discordant Patterns of Genetic Variation at Two Chloroquine Resistance Loci in Worldwide Populations of the Malaria Parasite Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2008
- Real-Time PCR Assay for Rapid Detection and Analysis of PfCRT Haplotypes of Chloroquine-Resistant Plasmodium falciparum Isolates from IndiaJournal of Clinical Microbiology, 2007
- Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in UgandaAntimicrobial Agents and Chemotherapy, 2007
- Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from AfricaInfection, Genetics and Evolution, 2006
- Occurrence of the Southeast Asian/South American SVMNT Haplotype of the Chloroquine‐Resistance Transporter Gene inPlasmodium falciparumin TanzaniaThe Journal of Infectious Diseases, 2006
- pfcrtPolymorphism and the Spread of Chloroquine Resistance inPlasmodium falciparumPopulations across the Amazon BasinThe Journal of Infectious Diseases, 2004
- Roll Back Malaria campaign still has a long way to goBMJ, 2003